But clinical evidence that IV glutathione improves outcomes during GLP-1 therapy does not exist
Missing occasional applications is less concerning than sporadic, inconsistent use
As a result, most subjects will require a higher dose of intranasal spray to achieve comparable results to injectable MT-II
Improved skin elasticity and thickness
Some glutathione formulations may contain sulfite residues
Diabetes 64(3):715717 Aldawsari M, Almadani FA, Almuhammadi N, Algabsani S, Alamro Y, Aldhwayan M (2023) The efficacy of GLP-1 analogues on appetite parameters, gastric emptying, food preference and taste among adults with obesity: systematic review of randomized controlled trials